scholarly journals Highly Porous Amorphous Calcium Phosphate for Drug Delivery and Bio-Medical Applications

Nanomaterials ◽  
2019 ◽  
Vol 10 (1) ◽  
pp. 20 ◽  
Author(s):  
Rui Sun ◽  
Michelle Åhlén ◽  
Cheuk-Wai Tai ◽  
Éva G. Bajnóczi ◽  
Fenne de Kleijne ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Calcium Phosphate ◽  
Amorphous Calcium Phosphate ◽  
Large Angle ◽  
Drug Carriers ◽  
Amorphous Calcium Carbonate ◽  
Practical Applications ◽  
The Stability ◽  
Highly Porous

Amorphous calcium phosphate (ACP) has shown significant effects on the biomineralization and promising applications in bio-medicine. However, the limited stability and porosity of ACP material restrict its practical applications. A storage stable highly porous ACP with Brunauer–Emmett–Teller surface area of over 400 m2/g was synthesized by introducing phosphoric acid to a methanol suspension containing amorphous calcium carbonate nanoparticles. Electron microscopy revealed that the porous ACP was constructed with aggregated ACP nanoparticles with dimensions of several nanometers. Large angle X-ray scattering revealed a short-range atomic order of <20 Å in the ACP nanoparticles. The synthesized ACP demonstrated long-term stability and did not crystallize even after storage for over 14 months in air. The stability of the ACP in water and an α-MEM cell culture medium were also examined. The stability of ACP could be tuned by adjusting its chemical composition. The ACP synthesized in this work was cytocompatible and acted as drug carriers for the bisphosphonate drug alendronate (AL) in vitro. AL-loaded ACP released ~25% of the loaded AL in the first 22 days. These properties make ACP a promising candidate material for potential application in biomedical fields such as drug delivery and bone healing.

scholarly journals Evaluation of metallic brackets adhesion after the use of bleaching gels with and without amorphous calcium phosphate (ACP): in vitro study

2013 ◽  
Vol 18 (3) ◽  
pp. 101-106 ◽  
Author(s):  
Sissy Maria Mendes Machado ◽  
Diego Bruno Pinho do Nascimento ◽  
Robson Costa Silva ◽  
Sandro Cordeiro Loretto ◽  
David Normando
Keyword(s):  
Calcium Phosphate ◽  
Bond Strength ◽  
Amorphous Calcium Phosphate ◽  
Shear Bond Strength ◽  
Mechanical Test ◽  
In Vitro Study ◽  
Control Group ◽  
Test Machine ◽  
Tooth Whitening

OBJECTIVE: To evaluate in vitro the effects of tooth whitening using gel with Amorphous Calcium Phosphate (ACP) on the bond strength of metal brackets. METHODS: Thirty-six bovine incisors were sectioned at the crown-root interface, and the crowns were then placed in PVC cylinders. The specimens were divided into 3 groups (n = 12) according to whitening treatment and type of gel used, as follows: G1 (control) = no whitening; G2 = whitening with gel not containing ACP (Whiteness Perfect - FGM), G3 = whitening with gel containing ACP (Nite White ACP - Discus Dental). Groups G2 and G3 were subjected to 14 cycles of whitening followed by an interval of 15 days before the bonding of metal brackets. Shear bond strength testing was performed on a Kratos universal test machine at a speed of 0.5 mm/min. After the mechanical test, the specimens were assessed to determine the adhesive remnant index (ARI). The results were subjected to ANOVA, Tukey's test and Kruskal-Wallis test (5%). RESULTS: Significant differences were noted between the groups. Control group (G1 = 11.10 MPa) showed a statistically higher shear bond strength than the groups that underwent whitening (G2 = 5.40 Mpa, G3 = 3.73 MPa), which did not differ from each other. There were no significant differences between the groups in terms of ARI. CONCLUSION: Tooth whitening reduces the bond strength of metal brackets, whereas the presence of ACP in the whitening gel has no bearing on the results.

Calcium phosphate porous pellets as drug delivery systems: Effect of drug carrier composition on drug loading and in vitro release

2012 ◽  
Vol 32 (11) ◽  
pp. 2679-2690 ◽  
Author(s):  
Hiva Baradari ◽  
Chantal Damia ◽  
Maggy Dutreih-Colas ◽  
Etienne Laborde ◽  
Nathalie Pécout ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Calcium Phosphate ◽  
Drug Delivery Systems ◽  
Drug Carrier ◽  
Drug Loading ◽  
In Vitro Release ◽  
Delivery Systems ◽  
Vitro Release

scholarly journals Phosphoserine Functionalized Cements Preserve Metastable Phases, and Reprecipitate Octacalcium Phosphate, Hydroxyapatite, Dicalcium Phosphate, and Amorphous Calcium Phosphate, during Degradation, In Vitro

2019 ◽  
Vol 10 (4) ◽  
pp. 54 ◽  
Author(s):  
Joseph Lazraq Bystrom ◽  
Michael Pujari-Palmer
Keyword(s):  
Calcium Phosphate ◽  
Amorphous Calcium Phosphate ◽  
Octacalcium Phosphate ◽  
Ionic Concentration ◽  
Strong Adhesion ◽  
Acidic Conditions ◽  
Rapid Transformation ◽  
Comparable Mass

Phosphoserine modified cements (PMC) exhibit unique properties, including strong adhesion to tissues and biomaterials. While TTCP-PMCs remodel into bone in vivo, little is known regarding the bioactivity and physiochemical changes that occur during resorption. In the present study, changes in the mechanical strength and composition were evaluated for 28 days, for three formulations of αTCP based PMCs. PMCs were significantly stronger than unmodified cement (38–49 MPa vs. 10 MPa). Inclusion of wollastonite in PMCs appeared to accelerate the conversion to hydroxyapatite, coincident with slight decrease in strength. In non-wollastonite PMCs the initial compressive strength did not change after 28 days in PBS (p > 0.99). Dissolution/degradation of PMC was evaluated in acidic (pH 2.7, pH 4.0), and supersaturated fluids (simulated body fluid (SBF)). PMCs exhibited comparable mass loss (<15%) after 14 days, regardless of pH and ionic concentration. Electron microscopy, infrared spectroscopy, and X-ray analysis revealed that significant amounts of brushite, octacalcium phosphate, and hydroxyapatite reprecipitated, following dissolution in acidic conditions (pH 2.7), while amorphous calcium phosphate formed in SBF. In conclusion, PMC surfaces remodel into metastable precursors to hydroxyapatite, in both acidic and neutral environments. By tuning the composition of PMCs, durable strength in fluids, and rapid transformation can be obtained.

In Situ Precipitation of Amorphous Calcium Phosphate and Ciprofloxacin Crystals during the Formation of Chitosan Hydrogels and Its Application for Drug Delivery Purposes

Langmuir ◽  
2012 ◽  
Vol 28 (45) ◽  
pp. 15937-15946 ◽  
Author(s):  
Stefania Nardecchia ◽  
María C. Gutiérrez ◽  
M. Concepción Serrano ◽  
Mariella Dentini ◽  
Andrea Barbetta ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Calcium Phosphate ◽  
Amorphous Calcium Phosphate ◽  
Chitosan Hydrogels

scholarly journals Efficiency of Amorphous Calcium Phosphate–Containing Orthodontic Composite and Resin Modified Glass Ionomer on Demineralization Evaluated By a New Laser Fluorescence Device

2009 ◽  
Vol 03 (02) ◽  
pp. 127-134 ◽  
Author(s):  
Tancan Uysal ◽  
Mihri Amasyali ◽  
Alp Erdin Koyuturk ◽  
Deniz Sagdic
Keyword(s):  
Calcium Phosphate ◽  
Amorphous Calcium Phosphate ◽  
Glass Ionomer Cement ◽  
Laser Fluorescence ◽  
Orthodontic Brackets ◽  
Glass Ionomer ◽  
Enamel Demineralization ◽  
Significant Difference ◽  
Resin Modified Glass Ionomer

ABSTRACTObjectives: The aim of this in vitro study was to compare the efficacy of Amorphous Calcium Phosphate (ACP)-containing orthodontic composite and resin-modified glass ionomer cement (RMGIC) on enamel demineralization adjacent to orthodontic brackets evaluated by a new laser fluorescence device.Methods: Sixty extracted maxillary premolars were used in the present study. Twenty orthodontic brackets were bonded with ACP-containing orthodontic adhesive (Aegis-Ortho), 20 were bonded with RMGIC (Fuji Ortho LC) ad20 were bonded with Transbond XT composite as the control. All samples were then cycled for 21 days through a daily procedure of demineralization for 6 hours and remineralization for 17 hours. After this procedure, demineralization evaluations were undertaken by a pen-type laser fluorescence device (DIAGNO-dent Pen). Analysis ofvariance (ANOVA) and Tukey test was used for statistical evaluation, at P<.05 level.Results: According to ANOVA, significant demineralization variations (ΔD) were determined among groups (F=6.650; P<.01). The ACP-containing composite showed the lowest (mean: 8.98±2.38) and the control composite showed the highest (mean:12.15±3.83) ΔD, during 21 days demineralization process (P<.01). Significant difference was also observed between the ΔD scores of the RMGIC (mean: 9.24±2.73) and control (P<.05).No significant differences was found in preventive effects of ACP-containing composite and RMGIC (P<.05) against demineralization.Conclusions: The use of both ACP-containing orthodontic composite and RMGIC should be recommended for any at-risk orthodontic patient to provide preventive actions and potentially remineralize subclinical enamel demineralization. (Eur J Dent 2009;3:127-134)

scholarly journals A Versatile Polymer Micelle Drug Delivery System for Encapsulation and In Vivo Stabilization of Hydrophobic Anticancer Drugs

2012 ◽  
Vol 2012 ◽  
pp. 1-8 ◽  
Author(s):  
Jonathan Rios-Doria ◽  
Adam Carie ◽  
Tara Costich ◽  
Brian Burke ◽  
Habib Skaff ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Drug Delivery System ◽  
Delivery System ◽  
Biological Fluids ◽  
Drug Carriers ◽  
Chemotherapeutic Drugs ◽  
Polymer Micelle ◽  
Drug Stabilization

Chemotherapeutic drugs are widely used for the treatment of cancer; however, use of these drugs is often associated with patient toxicity and poor tumor delivery. Micellar drug carriers offer a promising approach for formulating and achieving improved delivery of hydrophobic chemotherapeutic drugs; however, conventional micelles do not have long-term stability in complex biological environments such as plasma. To address this problem, a novel triblock copolymer has been developed to encapsulate several different hydrophobic drugs into stable polymer micelles. These micelles have been engineered to be stable at low concentrations even in complex biological fluids, and to release cargo in response to low pH environments, such as in the tumor microenvironment or in tumor cell endosomes. The particle sizes of drugs encapsulated ranged between 30–80 nm, with no relationship to the hydrophobicity of the drug. Stabilization of the micelles below the critical micelle concentration was demonstrated using a pH-reversible crosslinking mechanism, with proof-of-concept demonstrated in both in vitro and in vivo models. Described herein is polymer micelle drug delivery system that enables encapsulation and stabilization of a wide variety of chemotherapeutic drugs in a single platform.

Sign in / Sign up

Export Citation Format

Share Document